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ABSTRACT
Objectives: The source of research may influence
one’s interpretation of it in either negative or positive
ways, however, there are no robust experiments to
determine how source impacts on one’s judgment of
the research article. We determine the impact of source
on respondents’ assessment of the quality and
relevance of selected research abstracts.
Design: Web-based survey design using four
healthcare research abstracts previously published and
included in Cochrane Reviews.
Setting: All Council on the Education of Public Health-
accredited Schools and Programmes of Public Health
in the USA.
Participants: 899 core faculty members (full,
associate and assistant professors)
Intervention: Each of the four abstracts appeared
with a high-income source half of the time, and low-
income source half of the time. Participants each
reviewed the same four abstracts, but were randomly
allocated to receive two abstracts with high-income
source, and two abstracts with low-income source,
allowing for within-abstract comparison of quality
and relevance
Primary outcome measures: Within-abstract
comparison of participants’ rating scores on two
measures—strength of the evidence, and likelihood
of referral to a peer (1–10 rating scale). OR was
calculated using a generalised ordered logit model
adjusting for sociodemographic covariates.
Results: Participants who received high income
country source abstracts were equal in all known
characteristics to the participants who received the
abstracts with low income country sources. For one
of the four abstracts (a randomised, controlled trial
of a pharmaceutical intervention), likelihood of
referral to a peer was greater if the source was a
high income country (OR 1.28, 1.02 to 1.62,
p<0.05).
Conclusions: All things being equal, in one of the
four abstracts, the respondents were influenced by a
high-income source in their rating of research
abstracts. More research may be needed to explore
how the origin of a research article may lead to
stereotype activation and application in research
evaluation.
BACKGROUND
Ideally, research findings ought to be judged
on the strength of the evidence and their
relevance. However, there is subjectivity
involved in interpreting research.1 Research
certainly does not ‘speak for itself’—we give
it a voice—and how we judge whether one
piece of research constitutes evidence or not
is complex and messy. Common standards
for assessing the internal validity of research
do not account for the potential cognitive
biases in the consumption and interpretation
of research postpublication, and each of us
may reach a different conclusion as to
whether the research presents strong evi-
dence and whether we consider the research
useful. In practice, we see many idiosyncra-
cies. A rigorous randomised controlled trial
(RCT) may convince a surgeon to change a
certain practice, but may not have the same
effect on a primary care physician.2
Government regulators consider the reliabil-
ity (the degree to which an innovation is
communicated as being consistent in its
Strengths and limitations of this study
▪ First study at the national level in the USA, to
determine the impact of country-of-origin on the
rating of healthcare research abstracts.
▪ All core faculty members (full, associate and
assistant professors) of every Council on the
Education of Public Health-accredited Schools
and Programmes of Public Health in the USA
were invited to participate in the study.
▪ Participants were blinded to the purpose of the
study and randomised to receive high-income or
low-income source abstracts.
▪ Abstracts were rated on strength of the evidence
and likelihood of referral to a peer.
▪ Although 899 full, associate and assistant pro-
fessors participated in the study, this corre-
sponded to a 9.8% response rate.
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results) of an innovation more positively than do indus-
trial scientists.3 Clinicians are more likely to adopt an
innovation if they believe it has come from current users
with similar professional, cultural and socioeconomic
backgrounds.4 A legitimate source is important for
innovation diffusion,5 6 but little is known about how
legitimacy is defined or perceived. From the marketing
literature, Bilkey and Nes5 showed that consumers tend
to rate products from their own countries more favour-
ably and that consumer preferences are positively corre-
lated with the degree of economic development of the
source country, probably evoked by the lower price cue
of low income country products.7 Up to 30% of the vari-
ance of consumer product ratings can be attributed to
the product’s country-of-origin.8
In healthcare research, typically, the first pieces of
information to be provided in a research article are the
author’s name, and the institution and country the
research has been conducted in. Understanding anchor-
ing to be a feature of heuristic thought,9–13 it follows
that we should examine the extent to which the source
affects our interpretation of that research. If one pos-
sesses a prior-held belief or attitude towards the source,
how does this influence one’s subsequent view of the
research? All things being equal, would research con-
ducted in Ethiopia be viewed in the same way as identi-
cal research conducted in the USA?14
The income and development level of the source
country certainly seems to determine whether a manu-
script is selected for publication.15 The number of publi-
cations from low income countries is significantly lower
than the number from developed countries, in various
research fields.15 16 In psychiatry, only 6% of the litera-
ture is published from regions that represent 90% of the
global population.17 Similar under-representation exists
in cardiology, HIV research and epidemiology.18 19 One
argument for this is that research from low income
countries (LICs) lacks the quality to meet publication
criteria.20 Others argue that there are systematic selec-
tion biases. Editorial board members of international
biomedical journals are more likely to come from high
income countries (HICs).21–23 Reviewers from OECD
(Organization for Economic Cooperation and
Development) countries view articles from their own
country more favourably than they do articles from
other countries.22 24 25 Studies recruiting participants
from the USA are more likely to be published.21 23 In
Peters and Ceci’s26 controversial experiment, only one
of the nine articles that were initially published in a
highly regarded American journal was accepted on
resubmission to the same journal after fabricating the
name of the original institutions. Kliewer et al27 demon-
strated that articles from outside of North America were
less likely to be accepted for publication. It seems that
source matters.
The major obstacle to this research question is that
there are no controlled studies to ascertain the impact
of the source of the research post-publication. To fill this
research gap, we present here a randomised trial of
Public Health research faculty in the USA. This national
survey invites respondents, most of whom are experi-
enced healthcare researchers and peer reviewers, to rate
identical, typical healthcare research abstracts. To ascer-
tain the impact of the source (institution and country)
of the abstracts, we ensured that the abstracts that the
respondents received were identical in every respect,
however, we fictionalised the sources into either HIC or
LIC and randomised the respondents to receive either
type. We then compared their responses to two simple
questions for each abstract—whether they think the evi-
dence in the abstract is strong, and whether they would
recommend the abstract to a peer. Under the null
hypothesis, there should be no difference in the distri-
bution of responses to the two types of abstract.
METHODS
Survey design
We used a web-based survey using a Qualtrics survey plat-
form. The survey was divided into two sections, the first
to collect demographic and professional data, and the
second for the respondent to read and respond to four
research abstracts. Each abstract was followed by the
same two questions—first, how strong is the evidence
presented in this abstract? And second, how likely are
you to recommend this abstract to a colleague?
Responses were on a scale (1–10) with 1 as the least (ie,
not at all strong, not at all likely) and 10 as the most
(extremely strong, extremely likely). The time taken to
read and respond to each abstract was measured by the
survey platform. Each question was forced response to
avoid the problem of missing data. Recipients were ran-
domly allocated to one of two possible surveys. In the
first, abstracts 1 and 4 were fictionalised to HIC sources
(UK and Germany) and abstracts 2 and 3 were fictiona-
lised to LIC sources (Malawi and Ethiopia). These
sources were reversed in the second survey. Therefore,
each survey (survey A and survey B) had two abstracts
from LIC sources and two from HIC sources (figure 1).
In order to ensure that the abstracts were of sufficient
quality and internal validity, we purposively selected
abstracts of papers that had been included in Cochrane
Reviews and that were also likely to be of at least some
interest to most public health academics and health
service researchers. Each abstract had therefore already
been vetted for sources of bias prior to publication,
using the Cochrane risk of bias tool, and we only
selected abstracts that had a high internal validity for
the type of study that it was describing. There is a trade
off between choosing abstracts of interest to all potential
respondents and the length of the survey. We decided to
choose four abstracts—one randomised controlled
pharmaceutical trial, one randomised controlled service
intervention, one pharmaceutical intervention of cross-
sectional design and one service intervention of cross-
sectional design—to give a balance in terms of content
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and design. All four abstracts were of similar length and
complexity. The abstracts were presented as found in
their PubMed format, with all technical content pre-
served and in a format familiar to any healthcare
researcher, however, for each abstract, the institution
and country of origin was fictionalised to one of four dif-
ferent high-income or low-income sources. For one
abstract, the trial acronym was removed to avoid the pos-
sibility that some respondents would recognise the
research. High-income source countries were selected
from the top 10 countries by gross domestic profit
(GDP) per capita (>$36 000 per capita), and OECD
membership. Low-income source countries were
selected from the bottom 10 countries by GDP per
capita (<$1046 per capita). The institutional affiliation
was fictionalised to one of the top-five universities
that also had a medical or healthcare faculty, in
the respective countries. We used the 2014 Times
Higher Education World rankings (http://www.
timeshighereducation.co.uk/world-university-rankings/
2014-15/world-ranking) for the HIC sources, and the
http://www.4icu.org website for international rankings
of institutions for the low-income sources.
We ensured that the source of the abstract was equally
visible in each abstract and was mentioned in at least
three locations throughout the abstract—the title, under
the title and in the abstract itself. To avoid a possible
order effect, the order in which the abstracts were pre-
sented in the survey was randomised for each partici-
pant. Neither the original nor the fictionalised journals
were included in the source in order to avoid respon-
dents reacting to the reputation of the publication type.
Furthermore, in order to not influence the responses,
the survey was described as a Speed Reading survey,
designed to examine whether the time taken to read an
abstract influences the interpretation of the information
within it. The survey platform enabled us to measure the
time taken to respond to the entire survey, and each
abstract, and this information was provided to the
respondent at the end of the survey to heighten the ‘psy-
chological realism’ of the survey. The survey was pilot-
tested with Masters in Public Health students at Imperial
College London and some faculty members at New York
University, to ensure face validity of the questions and
also to ensure that the design and flow of the survey
were straightforward.
Participants and survey management
We included all core faculty members of Schools and
Programmes of Public Health—located in a US state—
that had publically available contact information and
that were accredited by the Council on the Education of
Public Health (CEPH—http://ceph.org/accredited)
(159 institutions; see online supplementary appendix
1 for full listing). We excluded administrators, managers,
adjunct faculty members and visiting faculty members,
and faculty members from our own institution. From
this universe of potential respondents (n=9421 once
duplicates were removed), we randomised them to
receive either survey A or survey B and sent them
an invite to take the survey. Block randomisation
within respective institutions was used, with four, six and
eight sequences, from a web-based randomisation
service (http://www.sealedenvelope.com, seed 13752665
5595533).
Figure 1 List of abstracts used in the survey and the fictionalised sources and institutions.
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The survey was designed so that only the email
recipient could open the link to the survey and that it
could be taken only one time. The survey could not be
sent anonymously, and was inaccessible to search
engines. The survey was active only within the specified
time frame (20 January–4 February 2015, chosen so
that faculty members were highly likely to be present at
their institution), and two email reminders were sent
on day 7 and day 14 following the first email invite (20
January 2015). Panel members did not receive prior
invitation to participate in the survey, however, our
email invite indicated clearly that all responses were to
be de-identified and analysed in aggregate form only,
and solely for the purposes of this research. It also
indicated that there was no obligation to participate
but by choosing to participate consent to use the
response for research is implied. We offered partici-
pants entry into a lottery draw for a $500 Amazon
voucher as an incentive to complete the survey. The
study protocol, including the non-harmful deception
around the ulterior motive of the study, was reviewed
by the New York University Committee on Activities
Involving Human Subjects and deemed exempt from
full ethical review (#14-10332).
Statistical analysis and power calculation
Data were retrieved via Qualtrics in CSV format and ana-
lysed using Stata/SE V.13 (Statacorp, College Station,
Texas, USA). We used demographic covariates (age,
sex), professional experience covariates (research expos-
ure, peer review experience, educational attainment)
and institutional covariates (region, CEPH accreditation
type and Ivy League status) to explain variation in the
outcomes of interest. We grouped respondent age into
categories based on a presumed mid-year birth and
survey completion date of 31 January 2015. Educational
attainment was categorised into two groups—Academic
and Clinical Academic—based on the completed qualifi-
cations provided in the survey responses. We used a gen-
eralised ordered logit model for the multivariable
analysis and two-tailed t tests to compare the differences
in mean responses as well as for the descriptive
characteristics of the survey samples. We also explored
high and low cut points for the outcome variables in
bivariate analysis and illustrate the distribution of scores
as proportions of respondents at the high (≥8) and low
(≤3) ends of the distribution, using a univariate logistic
regression model containing the binary outcome (ie,
above/below a certain threshold) and a binary indicator
of the abstract’s country of origin. The corresponding
test is a Wald test of the β coefficient for the abstract
country of origin.
We calculated that sample sizes of 400 respondents for
each survey would provide enough power (80%) to
detect a statistically significant (95% confidence level)
difference of 0.35 in mean scores between the two
groups.28
RESULTS
After randomisation, 4711 potential respondents
received email-invites for survey A, and 4710 received
email-invites for survey B. Fifty-one and 61 invitations
bounced, respectively. A total of 567 started survey A
and 594 started survey B. Of these, 433 completed
survey A and 466 completed survey B. This corresponds
to a response rate of 9.2% for survey A and 9.9% for
survey B. Institutional characteristics (region and Ivy
League representation) of responders and invitees were
not significantly different, although there was a small
over-representation of responders from CEPH-accredited
Programmes in Public Health. The demographic
Table 1 Respondent characteristics for survey A and survey B
All respondents (n=899) Survey A (n=433) Survey B (n=466)
Males, % 42.05 42.49 41.63
Age, mean 50.26 50.35 50.17
Academic credentials only*, % 84.58 84.69 84.48
Clinical credentials†, % 15.42 15.31 15.52
US born‡, % 81.65 82.68 80.69
Reads research daily§, % 60.07 61.20 59.01
CEPH Programme of Public Health¶, % 35.48 34.64 36.27
Ivy League university**, % 12.46 12.93 12.02
Region Northeast % 28.03 26.79 29.18
South % 42.05 43.42 40.77
Midwest % 18.24 17.32 19.1
West % 11.68 12.47 10.94
*For example, BSc, BA, MSc, MPH, PhD.
†For example, MD, MBBS, MBChB.
‡Versus non-US born.
§Versus reads research less than daily.
¶Versus CEPH School of Public Health.
**Versus non-Ivy League institution.
CEPH, Council on the Education of Public Health.
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characteristics of the respondents of both surveys were
equal, suggesting that randomisation performed as was
expected (table 1). Ninety per cent of respondents of
both survey types serve as peer reviewers for academic
journals.
On average, respondents spent between 72.5 and
109.9 s on each abstract with no significant differences
between the groups. table 2 shows the mean (SD)
ratings for strength and referral for the four abstracts by
the type of source. Referral to a peer for abstract 3 (ran-
domised controlled trial of a pharmaceutical interven-
tion) was significantly more likely if the source was from
a HIC. There were no other significant differences
between the abstracts based on the source. The findings
were unchanged when using a proportion rating higher
than eight or lower than three. As might be expected,
strength rating for abstracts that described a more robust
research design, specifically RCTs (abstract 1 and 3),
scored higher for strength than abstracts 2 and 4, which
were of a cross-sectional design. Also, as might be
expected, the disposal of these abstracts also correlated
well with respondents’ view of the strength of the evi-
dence contained within them. Correlation between the
scores given for strength of evidence and subsequent
referral was high (Spearman correlation coefficients
varied between 0.71 and 0.85).
Tables 3 and 4 show the results of the multivariable
analysis. Controlling for individual and institutional cov-
ariates, high-income source was a significant predictor of
referral for abstract 3 only (OR 1.28, 1.02 to 1.62). For
some abstracts, the time spent reviewing the abstract was
negatively associated with the rating given to it for
strength of evidence (abstract 1 OR 0.49, 0.34 to 0.71;
abstract 3 OR 0.65, 0.46 to 0.92) or referral to a peer
(abstract 1 OR 0.50, 0.35 to 0.72; abstract 2 OR 0.61,
0.44 to 0.84; abstract 3 OR 0.66, 0.44 to 0.84). However,
rating for abstract 4 (both strength of evidence (OR
1.63, 1.06 to 2.51) and referral to a peer (OR 1.55, 1.01
to 2.38) improved when more time was spent on it.
Individuals affiliated to CEPH Programmes of Public
Health were significantly more likely to rate the strength
of the evidence for this abstract higher (OR 1.38, 1.07 to
1.78) and to refer it to colleagues (OR 1.67, 1.30 to
2.15) than individuals affiliated to Schools of Public
Health.
DISCUSSION
Two sinister issues may be occurring if the source of the
research affects one’s judgement of it. First, poor
research may be given undue significance in part
because of the perceived legitimacy of its source. The
MMR scandal in the UK may have been a painful
example of this. In this case, vaccination rates for the
MMR immunisation plummeted when a study published
by a high profile research group in a prestigious journal
claimed a tenuous (and later discredited) connection
between the immunisation and rates of autism.29
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Second, good research from an unexpected source
may be discounted early on, resulting in missed oppor-
tunities to learn from important innovations. LICs have
developed novel innovations and there are multiple
opportunities to learn from LICs, for example, around
improved surgical procedures,30 improved long-term
outcomes in mental illness,31–35 improved skill mix with
scaled use of community health workers.36–38 However,
there are strikingly few examples where these innovations
have been adopted in HICs.39 Even in Health Links,
where HICs and LICs collaborate explicitly and recipro-
cally, there are surprisingly few examples of attempts to
adopt LIC innovations in high-income settings—HIC
volunteers learn a lot personally and professionally,
however, this does not translate into changes in their own
healthcare systems, and the learning and exchange of
expertise is predominantly directed from the HICs
towards the LICs.40–43 The Reverse Innovation ‘move-
ment’ sets out to unpack the barriers to adopting LIC
innovations in HIC contexts. It is motivated in part by the
rapidly changing global health landscape, and has gained
interest in the USA and UK because the unsustainable
growth in healthcare expenditure means that there is
likely to be a genuine need to learn from LICs.44
We know already from the Diffusion of Innovation lit-
erature that healthcare professionals perform poorly
when it comes to adopting innovations or evidence from
‘elsewhere.’2 7 The not-invented-here culture prevails.
However, we also know that innovations are more likely
to diffuse if actors perceive the source to be similar to
their own. Health professionals are homophilus.4 We
might ask, therefore, whether health professionals are
even more discriminating when presented with research
from very ‘unlikely’ sources? Do they discriminate
against sources that they might perceive to be so differ-
ent from their own, or perceive to be so unlikely to
produce good research, that the evidence is discounted
early on?
Table 3 Predictors of abstract strength ratings †
Abstract 1
OR
95% CI
Abstract 2
OR
95% CI
Abstract 3
OR
95% CI
Abstract 4
OR
95% CI
High vs low country origin 1.03
0.82 to 1.30
1
0.80 to 1.26
1.16
0.92 to 1.46
0.94
0.74 to 1.18
Male (vs female) 0.93
0.73 to 1.18
0.87
0.68 to 1.10
0.97
0.76 to 1.23
0.87
0.68 to 1.10
41–50 years (vs 21–40) 0.81
0.59 to 1.12
0.71*
0.52 to 0.97
1.01
0.73 to 1.39
0.87
0.64 to 1.20
51–60 years (vs 21–40) 0.79
0.57 to 1.09
0.74
0.54 to 1.03
1.14
0.82 to 1.58
0.77
0.56 to 1.06
61+ years (vs 21–40) 0.76
0.54 to 1.06
0.85
0.60 to 1.19
1.12
0.80 to 1.57
0.82
0.58 to 1.15
Clinical academic credentials (vs academic only) 0.83
0.60 to 1.14
0.65**
0.47 to 0.89
0.95
0.68 to 1.32
0.78
0.57 to 1.08
US born (vs not) 1.06
0.78 to 1.44
0.83
0.62 to 1.13
0.94
0.69 to 1.28
0.89
0.66 to 1.21
Reads research daily (vs <daily) 1.03
0.81 to 1.31
0.94
0.74 to 1.20
0.85
0.67 to 1.08
1.14
0.89 to 1.45
CEPH programme (vs school) 1.12
0.87 to 1.45
1.06
0.82 to 1.36
1.03
0.80 to 1.32
1.38*
1.07 to 1.78
Ivy League institution (vs others) 0.78
0.50 to 1.21
0.67
0.43 to 1.06
1.14
0.73 to 1.78
1.08
0.69 to 1.68
South region (vs Northeast) 0.71
0.50 to 1.00
1.08
0.77 to 1.52
0.84
0.59 to 1.18
1.05
0.74 to 1.47
Midwest region (vs Northeast) 0.82
0.55 to 1.23
1.17
0.78 to 1.74
1.14
0.76 to 1.71
1.07
0.72 to 1.59
West region (vs Northeast) 0.93
0.59 to 1.46
1.11
0.72 to 1.74
1.05
0.66 to 1.67
0.89
0.56 to 1.40
60–<120 s spent reading (vs <60 s) 0.67**
0.51 to 0.87
0.87
0.66 to 1.15
0.98
0.74 to 1.28
1.33*
1.04 to 1.70
120+ s spent reading (vs <60 s) 0.49***
0.34 to 0.71
0.77
0.56 to 1.07
0.65*
0.46 to 0.92
1.63*
1.06 to 2.51
N‡ 895 895 895 895
*p<0.05; **p<0.01; ***p<0.001.
†Generalised ordered logit model controlling for all variables in each column.
‡Only survey responses with no missing data included in the multivariate analysis.
Abstract 1, RCT/Service; Abstract 2, Cross-sectional/Service; Abstract 3, RCT/Pharmaceutical; Abstract 4, Cross-sectional/Pharmaceutical.
RCT, randomised controlled trial.
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We were motivated to conduct this study due to a
strong expectation that there would be a bias against
LIC abstracts, or at least that source would make a differ-
ence to how the respondents viewed the strength of evi-
dence in the abstract and whether they would choose to
refer the abstract to a peer. Although we found no
difference in three of the four abstracts, a high-income
source did make a difference to participants’ view of the
relevance of one of the abstracts. All things being equal,
our sample population considered the RCT of the
pharmaceutical intervention to be significantly more
relevant to their peer group if its source was from the
UK rather than from Malawi.
We did take several steps to ensure that if explicit
biases existed then we would capture them. We rando-
mised the survey abstracts to control for known and
unknown confounders, and this was performed well,
as evidenced by the balanced characteristics of the two
survey groups. We framed the research as a Speed
Reading survey to encourage respondents to spend
the minimum time assessing the abstract and to allow
anchoring to specific pieces of information in the
abstract to occur, and we made no reference to the
hypothesis that we were testing to not influence the
responses. We achieved a large sample size to be able
to detect small, but meaningful, differences in the dis-
tribution of the responses—the completed-survey
response rate of nearly 10% is within the range
expected for a time-consuming, internet-based survey
with no preinvitation recruitment.45 The fact that the
survey was presented as a Speed Reading test may also
have reduced selection bias, in that its stated purpose
would not necessarily appeal to one type of
researcher, such as those with more global health
experience.
However, the result was less dramatic than we expected,
occurring in only one of the four abstracts, and it suggests
that explicit biases are small and difficult to detect across
Table 4 Predictors of abstract referral ratings†
Abstract 1
OR
95% CI
Abstract 1
OR
95% CI
Abstract 3
OR
95% CI
Abstract 4
OR
95% CI
High vs low country origin 0.85
0.67 to 1.07
0.94
0.75 to 1.19
1.28*
1.02 to 1.62
0.9
0.71 to 1.13
Male (vs female) 0.95
0.75 to 1.20
0.78*
0.61 to 0.99
0.98
0.78 to 1.25
0.84
0.66 to 1.06
41–50 years (vs 21–40) 0.98
0.72 to 1.34
0.85
0.62 to 1.16
1.06
0.77 to 1.46
0.83
0.61 to 1.15
51–60 years (vs 21–40) 0.92
0.67 to 1.28
0.83
0.60 to 1.15
1.15
0.83 to 1.60
0.8
0.58 to 1.11
61+ years (vs 21–40) 1.07
0.77 to 1.50
1.09
0.77 to 1.54
1.16
0.83 to 1.63
0.84
0.60 to 1.18
Clinical academic credentials (vs academic only) 0.92
0.67 to 1.26
0.75
0.54 to 1.04
0.92
0.66 to 1.28
0.79
0.57 to 1.08
US born (vs not) 0.91
0.67 to 1.23
0.8
0.59 to 1.09
0.84
0.61 to 1.14
1.01
0.74 to 1.38
Reads research daily (vs <daily) 0.95
0.75 to 1.21
0.97
0.76 to 1.23
0.93
0.74 to 1.19
1.1
0.86 to 1.39
CEPH programme (vs school) 1.26
0.98 to 1.62
1.12
0.87 to 1.43
1.11
0.86 to 1.43
1.67***
1.30 to 2.15
Ivy League institution (vs others) 0.8
0.52 to 1.24
0.71
0.46 to 1.11
0.92
0.59 to 1.43
0.96
0.62 to 1.49
South region (vs Northeast) 0.91
0.65 to 1.29
1.14
0.80 to 1.61
0.93
0.66 to 1.30
1.01
0.72 to 1.43
Midwest region (vs Northeast) 1.09
0.73 to 1.63
1.39
0.93 to 2.07
1.04
0.70 to 1.55
1.23
0.83 to 1.84
West region (vs Northeast) 1.16
0.74 to 1.82
1.2
0.77 to 1.89
0.88
0.56 to 1.39
0.97
0.62 to 1.52
60–<120 s spent reading (vs <60 s) 0.65**
0.50 to 0.84
0.73*
0.55 to 0.96
0.97
0.74 to 1.28
1.31*
1.02 to 1.67
120+ s spent reading (vs <60 s) 0.5***
0.35 to 0.72
0.61**
0.44 to 0.84
0.66*
0.47 to 0.93
1.55*
1.01 to 2.38
N‡ 895 895 895 895
*p<0.05; **p<0.01; ***p<0.001.
†Generalised ordered logit models controlling for all variables in each column.
‡Only survey responses with no missing data included in the multivariate analysis.
Abstract 1, RCT/Service; Abstract 2, Cross-sectional/Service; Abstract 3, RCT/Pharmaceutical; Abstract 4, Cross-sectional/Pharmaceutical.
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a relatively small group of abstracts. The study provides an
empirical baseline against which to compare future
research into the effect of source on abstract evaluation.
Indeed, it could be argued that the implications of this
study are encouraging for the population that partici-
pated because the two groups of survey respondents
treated three of the four abstracts almost identically, irre-
spective of the source. Public health faculty in the USA
seem to be doing what is expected of them. Research is
being assessed, by and large, according to its content
rather than its origin. For those interested in exploring
the barriers to Reverse Innovation, or types of publication
bias, this finding may be encouraging.
In our study, we also found that respondents spent on
average between 70 and 100 s per abstract. Rapid respon-
ders tended to rate abstracts higher, so it is possible that
if less time is spent on the abstracts then anchoring to
particular triggers might be having a greater effect. We
did find that, in Abstract 4, if more time is taken to
respond to the abstract then opinion of it improves (for
both strength of evidence and referral), however, this is
equal between high as well as low-income sources. We
also found, as would be expected, that respondents
tended to rate the randomised controlled trial abstracts
higher for strength of evidence compared to the
abstracts that were of a cross-sectional design. As the
study was framed as a Speed Reading assessment, survey
participants might have felt the need to speed-read the
abstracts, which may not mirror normal practice.
We also note that the wide SDs in the outcomes indi-
cate that, despite the large sample size, there is consider-
able variation in how readers view and consume
research. The wide SDs might have reduced our ability
to detect differences and further work should be con-
ducted to validate measurement constructs in this
context. GRADE46 and Jadad47 scores are widely used,
but usually to assess entire research articles against
judgement of research quality, risk of bias, inconsistency,
indirectness, imprecision and publication bias.48–54 Our
study, designed purposefully to be a rapid appraisal only
of the research abstract, demonstrated extremely wide
variation in the assessment of the limited information
provided in the abstracts. This finding may have implica-
tions for systematic reviews, meta-analyses and for
reviewers of abstracts submitted for conferences.
Considering the volume of abstracts read and con-
sumed on a daily basis from all parts of the globe, if
source impacts on one’s perception, even by a tiny
margin, this might, at scale, be an observable phenom-
enon. We cannot speculate as to the triggers individuals
identify with when reading each individual abstract under
relatively rapid, timed conditions, but it is encouraging
that overall there were few differences between the two
survey groups. As highly trained researchers in public
health, we could expect an explicit bias to be extremely
small, if present at all. It is possible that in other popula-
tion groups this survey would present different findings.
Policymakers, clinicians, journalists and health service
managers are all important actors in innovation diffusion
processes, and may also be involved in peer-review pro-
cesses for academic publication. Our strategy to include
academic public health professionals in this survey is
based on a best-case assessment of likely bias. Future
research ought to modify the approach we have chosen
in accordance with the target population, using other
abstracts or developing a research design that allows
respondents to serve as their own controls. Although we
found only one of the four abstracts eliciting a small (yet
statistically significant) difference in rating, it is unclear
whether this proportion would hold across the population
level in practice. It certainly raises the question of
whether abstracts and articles submitted for peer review
should be masked to country-of-origin.55 The eighth
International conference on peer review in biomedical
research sets the stage for a more detailed examination of
cognitive biases in healthcare evidence interpretation.56
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